Overview

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

Status:
Not yet recruiting

Trial end date:
2023-07-17

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to assess the effects of rifampin on the PK of brensocatib in Part 1 of the study and to assess the effects of esomeprazole on the PK of brensocatib in Part 2 of the study.

Phase:

Phase 1

Details

Lead Sponsor:

Insmed Incorporated

Treatments:

Esomeprazole
Rifampin